EGFR and neoplasm: However, despite these limitations, the results are compelling in that they demonstrate that tumor sidedness has the most significant correlation with outcomes, including patients who receive different chemotherapy treatments and biologic agents such as EGFR inhibitors or anti‐angiogenesis therapeutics.